Produkty 739-26-4

CAS 739-26-4 występuje w naszej ofercie pod nazwami: 11b-Hydroxy Etiocholanolone, >95% (HPLC), 11Beta-Hydroxy Etiocholanolone, >95% (HPLC), 11β–Hydroxyetiocholanolone, 11b-Hydroxy etiocholanolone, 11β-Hydroxyetiocholanolone. Oferty producentów: TRC, GLPBio, Biosynth, MedChemExpress. Dostępne opakowania: 50mg, 5mg, 1mg, 10mg, 25mg, 2mg, 1 mg, 25 mg.

11b-Hydroxy Etiocholanolone, >95% (HPLC)
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
11Beta-Hydroxy Etiocholanolone, >95% (HPLC)
TRC
  • opakowanie: 5mg
  • Warianty: 1
Zobacz produkt
11β–Hydroxyetiocholanolone
GLPBio
  • opakowanie: 1mg, 10mg, 25mg, 5mg
  • Warianty: 4
od 643,84
Zobacz produkt
11b-Hydroxy etiocholanolone
Biosynth
  • opakowanie: 2mg, 5mg, 10mg, 50mg
  • Warianty: 5
Zobacz produkt
11β-Hydroxyetiocholanolone
MedChemExpress
  • opakowanie: 1 mg, 25 mg, 5 mg, 10 mg
  • Warianty: 4
od 746,94
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one (CAS 739-26-4) to związek chemiczny o wzorze sumarycznym C19H30O3 i masie molowej 306.4 g/mol. Nazwa systematyczna IUPAC: (3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one. InChIKey: PIXFHVWJOVNKQK-DLAZEALESA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O3
Masa molowa306.4 g/mol
Nazwa IUPAC(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
InChIKeyPIXFHVWJOVNKQK-DLAZEALESA-N
SMILESC[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 11beta-Hydroxyetiocholanolone, 3alpha,11beta-Dihydroxy-5beta-androstan-17-one, 3alpha,11beta-Dihydroxy-5beta-androstane-17-one, Androstan-17-one, 3,11-dihydroxy-, (3.alpha.,5.beta.,11.beta.)-, 5.beta.-Androstan-3.alpha.,11.beta.-diol-17-one, 3.alpha.,11.beta.-Dihydroxy-5.beta.-androstan-17-one, Androstan-17-one, 3,11-dihydroxy-, (3alpha,5beta,11beta)-, 5beta-Androstan-3alpha,11beta-diol-17-one, 5beta-androstane-3alpha,11beta-diol-17-one, (3alpha,5beta,11beta)-3,11-Dihydroxyandrostan-17-one
Powiązane formy tego związku
(3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
Izomery (ten sam wzór sumaryczny)
dodecyl 2-hydroxybenzoate C19H30O3
dodecyl 4-hydroxybenzoate C19H30O3
ethyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate C19H30O3
(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one C19H30O3
(1S,3aS,3bR,5aS,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one C19H30O3
(4aS,4bR,6aR,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3
(3R,5R,8R,9S,10S,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3